# MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD)

> **NCT04428372** · PHASE2,PHASE3 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 31 (actual)

## Conditions studied

- Hemodialysis Complication
- Hemodynamic Instability

## Interventions

- **DRUG:** Mannitol
- **DRUG:** 0.9% saline

## Key facts

- **NCT ID:** NCT04428372
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-06
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04428372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04428372, "MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04428372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*